Claiborne Cary J

Chief Financial Officer at OSIRIS THERAPEUTICS, INC. · on record since Sep 28, 2006
Director at NeuroSense Therapeutics Ltd. · on record since Mar 18, 2026
Director at WIRELESS HOLDINGS INC · on record since May 29, 2009
CEO, CFO and President at WIRELESS HOLDINGS INC · on record since Dec 29, 2009
Director at SPECTRASCIENCE INC · on record since Feb 14, 2011
former CEO, CFO & Pres. at SPECTRASCIENCE INC · on record since Feb 14, 2011
Director at ADIAL PHARMACEUTICALS, INC. · on record since Apr 9, 2026
Chief Financial Officer at Sucampo Pharmaceuticals, Inc. · on record since Feb 28, 2014
Former Chief Financial Officer at Sucampo Pharmaceuticals, Inc. · on record since Dec 17, 2014
Director at CYTRX CORP · on record since Jul 28, 2022
Chief Executive Officer at ADIAL PHARMACEUTICALS, INC. · on record since Dec 8, 2021

Insider trading activity of Claiborne Cary J

Transactions on record: 84; since Feb 26, 2007

Open-market buys: 13; $28.2K

Open-market sells: 7; $734.6K

Companies traded: 6; last filing Apr 9, 2026

Figures computed from official regulatory filings — .

Companies where Claiborne Cary J has traded

ADIAL PHARMACEUTICALS, INC.12 tx · $42.3K · Apr 9, 2026
CYTRX CORP1 tx · Jan 29, 2024
Sucampo Pharmaceuticals, Inc.39 tx · $1.4M · Dec 17, 2014
SPECTRASCIENCE INC2 tx · Feb 14, 2011
WIRELESS HOLDINGS INC26 tx · $79.2K · Dec 29, 2009
4 tx · $484.4K · Nov 23, 2007

Track record of Claiborne Cary J

Statistical track record

Free

Open-market buys: 14

Last buy: Dec 28, 2009

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Claiborne Cary J

Co-insiders of Claiborne Cary J

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ADIAL PHARMACEUTICALS, INC.	Apr 9, 2026	Award	37,985	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Jun 2, 2025	AwardD (derivative)	138,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Dec 5, 2024	AwardD (derivative)	350,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Mar 27, 2024	AwardD (derivative)	60,000	0.00 USD	—	SEC
CYTRX CORP	Jan 29, 2024	AwardD (derivative)	5,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	May 25, 2023	Award	420,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	May 25, 2023	AwardD (derivative)	300,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Sep 20, 2022	Award	25,000	0.43 USD	$10.8K	SEC
ADIAL PHARMACEUTICALS, INC.	Sep 20, 2022	Award	75,000	0.42 USD	$31.5K	SEC
ADIAL PHARMACEUTICALS, INC.	Aug 22, 2022	Award	1,000,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Feb 25, 2022	AwardD (derivative)	6,667	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Dec 8, 2021	AwardD (derivative)	130,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Nov 3, 2021	AwardD (derivative)	60,000	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Exercise	42,900	4.07 USD	$174.6K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Exercise	7,100	4.07 USD	$28.9K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	ExerciseD (derivative)	-7,100	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Sell	-7,100	12.89 USD	$91.5K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Sell	-42,900	12.91 USD	$553.8K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	ExerciseD (derivative)	-42,900	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Sep 15, 2014	AwardD (derivative)	25,000	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Sep 15, 2014	AwardD (derivative)	22,027	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Jul 10, 2014	Award	220	6.79 USD	$1.5K	SEC
Sucampo Pharmaceuticals, Inc.	Jul 10, 2014	Award	267	6.56 USD	$1.8K	SEC
Sucampo Pharmaceuticals, Inc.	Feb 28, 2014	ExerciseD (derivative)	-2,500	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Feb 28, 2014	Sell	-110	9.06 USD	$996.6	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ADIAL PHARMACEUTICALS, INC.	Apr 9, 2026	Award	37,985	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Jun 2, 2025	AwardD (derivative)	138,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Dec 5, 2024	AwardD (derivative)	350,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Mar 27, 2024	AwardD (derivative)	60,000	0.00 USD	—	SEC
CYTRX CORP	Jan 29, 2024	AwardD (derivative)	5,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	May 25, 2023	Award	420,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	May 25, 2023	AwardD (derivative)	300,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Sep 20, 2022	Award	25,000	0.43 USD	$10.8K	SEC
ADIAL PHARMACEUTICALS, INC.	Sep 20, 2022	Award	75,000	0.42 USD	$31.5K	SEC
ADIAL PHARMACEUTICALS, INC.	Aug 22, 2022	Award	1,000,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Feb 25, 2022	AwardD (derivative)	6,667	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Dec 8, 2021	AwardD (derivative)	130,000	0.00 USD	—	SEC
ADIAL PHARMACEUTICALS, INC.	Nov 3, 2021	AwardD (derivative)	60,000	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Exercise	42,900	4.07 USD	$174.6K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Exercise	7,100	4.07 USD	$28.9K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	ExerciseD (derivative)	-7,100	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Sell	-7,100	12.89 USD	$91.5K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	Sell	-42,900	12.91 USD	$553.8K	SEC
Sucampo Pharmaceuticals, Inc.	Dec 17, 2014	ExerciseD (derivative)	-42,900	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Sep 15, 2014	AwardD (derivative)	25,000	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Sep 15, 2014	AwardD (derivative)	22,027	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Jul 10, 2014	Award	220	6.79 USD	$1.5K	SEC
Sucampo Pharmaceuticals, Inc.	Jul 10, 2014	Award	267	6.56 USD	$1.8K	SEC
Sucampo Pharmaceuticals, Inc.	Feb 28, 2014	ExerciseD (derivative)	-2,500	0.00 USD	—	SEC
Sucampo Pharmaceuticals, Inc.	Feb 28, 2014	Sell	-110	9.06 USD	$996.6	SEC